Skip to main content
Live · TradingView
Back to the NewsWire

Finance Yahoo

Published September 22, 2026

Optimi Health Appoints Dr. Michael Blough as Chief Clinical Development Officer

Read the full story at Finance Yahoo

Supports Optimi's planned Phase 2 psilocybin trial in major depressive disorder and Phase 3 MDMA trial in PTSDVANCOUVER, British Columbia, Sept.

Surfaced by 4 Google Alerts

  • MDMA
  • Psychedelics
  • Psychedelic crime
  • Psychedelic press release